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The most common etiologic agents of infective endocarditis are
Gram-positive bacteria – staphylococci, viridans streptococci, and
enterococci, which represent 50–70% of all bacterial isolates from
blood cultures in patients with infective endocarditis. Culture-
negative infective endocarditis represents 25–40% and Gram-
negative bacteria 5–10%.1–4
We assessed the proportion, etiology, risk factors, andmortality
of infective endocarditis due to Gram-negative bacteria within our
database of infective endocarditis in Slovakia. Endocarditis was
deﬁned according to the modiﬁed Duke criteria.
Out of 606 cases of infective endocarditis, 42 cases due to Gram-
negative bacteria were found (6.9%). The organisms isolated in the
42 cases were: Pseudomonas aeruginosa (8),Haemophilus inﬂuenzae
(6), Acinetobacter baumannii (6), Klebsiella pneumoniae (6),
Salmonella enteritidis (5), Pantoea agglomerans (4), Escherichia coli
(4), Citrobacter freundii (1), Serratia marcescens (1), and Pseudomo-
nas ﬂuorescens (1).
A comparison of the 564 cases of non-Gram-negative infective
endocarditis with the 42 cases of Gram-negative endocarditis, in
univariate analysis, is shown in Table 1. Diabetes mellitus type I
(10.3% vs. 26.2%; p = 0.002), prior endoscopy (6.4% vs. 31%;
p = 0.001), congenital heart disease (2.7% vs. 11.9%; p = 0.001),
dental surgery (12.4% vs. 23.8%; p = 0.04), and right side (2% vs.Table 1
Risk factors for Gram-negative endocarditis
Risk factor Non-Gram-
negative
endocarditis
(n=564)
Gram-
negative
endocarditis
(n=42)
p-Value
Elderly (age >65 years) 185 (32.8%) 15 (35.7%) NS
Rheumatic fever 130 (23.1%) 5 (11.9%) NS
Neoplasia 54 (9.6%) 2 (4.8%) NS
Diabetes mellitus 58 (10.3%) 11 (26.2%) 0.002
Intravenous drug abuse 5 (0.9%) 0 NS
Previous cardiac surgery 55 (9.8%) 5 (19.4%) NS
Prior endoscopy 36 (6.4%) 13 (31%) <0.001
Dialysis 28 (5%) 0 NS
Congenital heart disease 15 (2.7%) 5 (11.9%) 0.001
Dental surgery 70 (12.4%) 10 (23.8%) 0.04
Sinusitis/tonsillitis 39 (6.9%) 1 (2.4%) NS
Aortic valve involvement 272 (48.2%) 20 (47.6%) NS
Mitral valve involvement 179 (31.7%) 17 (40.5%) NS
Right side 11 (2%) 4 (9.5%) 0.002
Prosthetic valve 89 (15.8%) 1 (2.4%) 0.02
Embolization 198 (35.1%) 17 (40.5%) NS
Three or more positive
bacterial cultures
77 (13.7%) 8 (19.4%) NS
Antibiotics only 322 (57.1%) 26 (61.9%) NS
Antibiotics plus surgery 242 (42.9%) 16 (38.1%) NS
Death 87 (15.4%) 4 (9.5%) NS
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doi:10.1016/j.ijid.2009.08.0229.5%; p = 0.002), were signiﬁcantly more frequent in those with
Gram-negative endocarditis. In contrast, prosthetic valve insertion
(15.8% vs. 2.4%; p = 0.02) was less frequently observed among
infective endocarditis cases due to Gram-negative bacteria than
among non-Gram-negative cases. Themortality rate was similar in
both groups (15.4% vs. 9.5%; not signiﬁcant). The proportion of
infective endocarditis due to Gram-negative bacteria (6.9%) over
the course of 23 years in Slovakia is similar to the proportion of
Gram-negative infective endocarditis (5–10%) from other national
studies in Europe.2–4
Patients with diabetes mellitus type I, those having undergone
endoscopy of the gastrointestinal or genitourinary tract, thosewith
congenital heart disease, those having had dental surgery, and
those with right-sided endocarditis are at higher risk of Gram-
negative infective endocarditis. Therefore initial therapy with an
anti-Gram-negative antibiotic until etiology/susceptibility is
determined is advisable.
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